|Articles|October 2, 2015
Teva to Buy Leading Mexican Pharma Firm
October 02, 2015.
Advertisement
Teva (Petah Tikva, Israel) has entered into an agreement to acquire Mexican pharma company Representaciones e Investigaciones Médicas (Rimsa) for $2.3 billion,
Rimsa, which had a 2014 revenue of $227 million, has a portfolio of specialty products, including fixed-dose combination products. The company has a 45-year history as one of Mexico's companies; Mexico is the second largest healthcare market in Latin America.
Teva expects to close the transactions by Q1 2016.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
HHS Confirms Four Senior FDA Leaders, Including Agency's First-Ever AI Deputy Commissioner
2
How Elevated Cortisol Levels Can Impact Type II Diabetes Treatments
3
Kura Oncology Spins Out Caspian Therapeutics With $50 Million to Test Menin Inhibition as a Disease-Modifying Approach to Diabetes
4
IBD's Most Persistent Gap: Q&A with Christian Thienel
5